Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Hemoptysis | Research

Factors affecting in-hospital mortality of non-tuberculous mycobacterial pulmonary disease

Authors: Goh Tanaka, Taisuke Jo, Hiroyuki Tamiya, Yukiyo Sakamoto, Wakae Hasegawa, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Takahide Nagase

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

The incidence and prevalence of non-tuberculous mycobacterial pulmonary disease (NTM-PD) are reportedly increasing in many parts of the world. However, there are few published data on NTM-PD-related death. Using data from a national inpatient database in Japan, we aimed in this study to identify the characteristics of patients with NTM-PD and clinical deterioration and to identify risk factors for in-hospital mortality.

Methods

We examined data from the Diagnosis Procedure Combination (DPC) database in Japan from July 2010 to March 2014. We extracted data for HIV-negative NTM-PD patients who required unscheduled hospitalization. We evaluated these patients’ characteristics and performed multivariable logistic regression analysis to identify risk factors for all-cause in-hospital mortality.

Results

A total of 16,192 patients (median age: 78 years; women: 61.2%) were identified. The median body mass index (BMI) was 17.5 kg/m2 (IQR 15.4–20.0). All cause In-hospital death occurred in 3166 patients (19.6%). The median BMI of the patients who had died was 16.0 kg/m2 (IQR 14.2–18.4). Multivariable analysis revealed that increased mortality was associated with male sex, lower BMI, lower activities of daily living scores on the Barthel index, hemoptysis, and comorbidities, including pulmonary infection other than NTM, interstitial lung disease, pneumothorax, and malignant disease.

Conclusions

We found associations between being underweight and having several comorbidities and increased in-hospital mortality in patients with NTM-PD. Preventing weight loss and management of comorbidities may have a crucial role in improving this disease’s prognosis.
Literature
16.
go back to reference Japanese Society of Tuberculosis, Japanese Society of Respiratory Diseases. Opinions on chemotherapy of non-tuberculous acid-fast bacterial infection of the lung. Kekkaku. 2012;87:83–6 (in Japanese). Japanese Society of Tuberculosis, Japanese Society of Respiratory Diseases. Opinions on chemotherapy of non-tuberculous acid-fast bacterial infection of the lung. Kekkaku. 2012;87:83–6 (in Japanese).
21.
go back to reference Song JH, Kim BS, Kwak N, Han KD, Yim JJ. Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2021;57(2):2000454. PMID: 32817261. Song JH, Kim BS, Kwak N, Han KD, Yim JJ. Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2021;57(2):2000454. PMID: 32817261.
Metadata
Title
Factors affecting in-hospital mortality of non-tuberculous mycobacterial pulmonary disease
Authors
Goh Tanaka
Taisuke Jo
Hiroyuki Tamiya
Yukiyo Sakamoto
Wakae Hasegawa
Hiroki Matsui
Kiyohide Fushimi
Hideo Yasunaga
Takahide Nagase
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06395-y

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.